Myeloid-specific Klf4 deletion augments HFD-induced obesity, insulin resistance and adipose tissue inflammation (54), which is indicative of the systemic metabolic impact of KLF4-dependent regulation of macrophage activation. The gene discussed is KLF4; the disease is obesity due to melanocortin 4 receptor deficiency.